Global Health (MEDANTA) | Stock Overview & Key Data
Global Health Performance Comparison
Stock Range
Today's Range
Low: ₹1,347.00
High: ₹1,394.00
on August 13, 2025
52 Week Range
Low: ₹935.50
High: ₹1,456.50
on October 7, 2024
on August 8, 2025
All-Time High: ₹1,513.90 on February 12, 2024
Explore how other Indian stocks compare to their 52-week ranges: View IN Market 52-Week Insights
Key Statistics
Market Cap
INR372.6B
EPS
19.92
P/E Ratio (TTM)
69.59
Forward P/E
59.22
P/B Ratio
11.01
PEG Ratio
59.22
Div. Yield
N/A
ROE
15.30%
Beta
-0.322
Debt to Equity
21.19
Financial Highlights
Profitability
Gross Margin
76.81%
Operating Margin
18.84%
Profit Margin
13.04%
Returns and Earnings
Return on Assets (TTM)
9.42%
Return on Equity (TTM)
15.30%
EBITDA
INR9.9B
Net Income (TTM)
INR4.8B
Growth
Revenue (TTM)
Revenue Per Share (TTM)
INR137.47
Quarterly Revenue Growth (YoY)
12.80%
Quarterly Earnings Growth (YoY)
-20.40%
Peer Performance Comparison
| Company | Market Cap | 1W | 1M | 3M | 6M | YTD | 1Y | 3Y | 5Y |
|---|---|---|---|---|---|---|---|---|---|
| Global Health MEDANTA | 372.61B Large-cap | 4.03% | 3.99% | 12.48% | 26.66% | 25.40% | 23.24% | 235.00% | 235.00% |
| Max Healthcare MAXHEALTH | 1.23T Large-cap | -1.04% | 0.88% | 8.68% | 25.46% | 10.62% | 42.72% | 233.37% | 1,030.47% |
| Apollo Hospitals APOLLOHOSP | 1.04T Large-cap | -0.52% | 0.23% | 4.48% | 13.52% | -1.81% | 8.22% | 74.99% | 331.39% |
| Fortis Healthcare FORTIS | 677.54B Large-cap | 7.35% | 19.09% | 37.69% | 51.60% | 31.50% | 72.79% | 208.17% | 569.08% |
| Narayana Hrudayalaya NH | 358.59B Large-cap | -3.50% | -12.03% | -0.86% | 30.73% | 34.52% | 41.02% | 154.72% | 422.39% |
| Aster DM Healthcare ASTERDM | 302.08B Large-cap | 0.60% | 0.68% | 10.06% | 40.21% | 15.98% | 54.42% | 189.39% | 331.86% |
Ownership & Short Interest
Insider Ownership
67.60%
Institutional Ownership
20.66%
Shares Short
N/A
Short Ratio
N/A
Short % of Shares Outstanding
N/A
Average 10-Day Volume
663K
Average 90-Day Volume
583K
Global Health Recurring Investment / Dollar-Cost Averaging Calculator
Calculate how a regular investment in Global Health would have performed over time.
Note: This calculator is for informational purposes only and does not consider taxes, fees, or other costs associated with investing.
Frequently Asked Questions
- What is MEDANTA's 52-week high and low?
- In the last 52 weeks, Global Health reached a high of ₹1,456.50 (on August 8, 2025) and a low of ₹935.50 (on October 7, 2024).
- What is the market cap and P/E ratio for MEDANTA?
- Curious about Global Health's size and valuation? Its market capitalization stands at 372.61B. When it comes to valuation, the P/E ratio (trailing twelve months) is 69.59, and the forward P/E (looking ahead) is 59.22.
- Does MEDANTA pay dividends? If so, what's the yield?
- As for dividends, Global Health isn't currently offering a significant yield, or that specific data isn't available right now.
- Who are Global Health's main competitors or similar companies to consider before investing?
When looking at Global Health, it can be helpful to see how it compares to other players in its field. Here are a few similar companies or key competitors:
Company Mkt Cap Sector Industry 1Y Return 3Y Return Max Healthcare
MAXHEALTH1.23T Healthcare Medical Care Facilities 42.72% 233.37% Apollo Hospitals
APOLLOHOSP1.04T Healthcare Medical Care Facilities 8.22% 74.99% Fortis Healthcare
FORTIS677.54B Healthcare Medical Care Facilities 72.79% 208.17% Narayana Hrudayalaya
NH358.59B Healthcare Medical Care Facilities 41.02% 154.72% Aster DM Healthcare
ASTERDM302.08B Healthcare Medical Care Facilities 54.42% 189.39% For a more comprehensive list, please see the Peer Performance Comparison table on this page.
- What are the key financial health indicators for Global Health Ltd.? (e.g., ROE, Debt/Equity)
- To get a sense of Global Health's financial health, here are a few key indicators: its Return on Equity (ROE) over the last twelve months is 15.30%, the Debt to Equity ratio from the most recent quarter is 21.19, and its Gross Profit Margin stands at 76.81%.
- What is the recent revenue and earnings growth for MEDANTA?
- Looking at Global Health's growth, its revenue over the trailing twelve months (TTM) was INR37B. Compared to the same quarter last year (YoY), quarterly revenue grew by 12.80%, and quarterly earnings saw a YoY growth of -20.40%.
- How much of MEDANTA stock is held by insiders and institutions?
- Wondering who owns Global Health stock? Company insiders (like executives and directors) hold about 67.60% of the shares, while institutional investors (such as mutual funds and pension funds) own approximately 20.66%.
For more common questions about our data, please visit our About Data page.
Data is provided for informational purposes only. Devyara does not guarantee the accuracy of the data displayed.